Paul Marganski @paulBIOgeek

I am interested in technology, biotech, finance, networking, business development, and anything interesting. Planet Earth Joined October 2022

Tweets

2K
Followers

209
Following

451
Likes

353

Alnylam Pharmaceuticals @Alnylam

2 days ago

Leading the way in ATTR-CM!

0 2 8 559 0

Download Image

0 0 0 60 0

Oliver Venture @_OliverVenture

4 days ago

Hmmm

1 1 7 2K 6

Download Image

0 0 0 82 0

How did every single analyst miss Fab-25's impact on revenue/earnings for $SKYT until very recently?? This was a known event for a while. I was able to scoop up a ton of shares between $7-$8/share. Congrats to all SkyWater longs - today is just the beginning.

0 0 0 176 0

Paul Marganski @paulBIOgeek

4 days ago

What did I say about $SKYT?? Up over 10% pre-market. My average cost is in the $7 range. My largest position, even before today. #winning #squeeze

0 0 1 165 0

Paul Marganski @paulBIOgeek

5 days ago

Beautiful reversals in both $SKYT and $SOFI this morning...

1 0 0 243 0

Paul Marganski @paulBIOgeek

5 days ago

Stepped in to fill out my full position in $SOFI this morning, picking up shares around $27.40

0 0 1 132 0

Paul Marganski @paulBIOgeek

a week ago

I'm in about 22% cash at the moment. Looking for a new opportunity. Any ideas in finance, defense, or non-AI non-biotech? #stocks #investing

0 0 1 62 0

Brad Loncar @bradloncar

a week ago

It was obviously inevitable for Pfizer to do an obesity deal like this. Smart move to grab differentiated assets, plus covers the table on both GLP and amylin, and oral programs, in one transaction.

13 8 82 14K 6

Paul Marganski @paulBIOgeek

a week ago

Sold 15% of my $SKYT at $15.20+ today. I still hold my core position, which has nearly doubled.

0 0 0 234 0

Paul Marganski @paulBIOgeek

a week ago

$RHHBY + $ALNY = $$$

Michel Doepke @doepke_michel

a week ago

$RHHBY + $ALNY = $$$

0 2 26 3K 7

Download Image

0 0 0 157 0

Paul Marganski @paulBIOgeek

a week ago

Completely sold out of $WVE for a very small loss (<10%). I see much better Risk/Reward at the moment. Good data for WVE-007 this Fall may boost the stock, but this is a spec bet, at best. Taking my ball and going home to invest in better names.

0 0 0 193 0

Paul Marganski @paulBIOgeek

2 weeks ago

Sold 12% of my $SKYT around $13.75 today. I'm still very overweight on them, but I feel we could run tib$18-$20 here, where I'll sell another 12-18%.

0 0 1 187 0

Paul Marganski @paulBIOgeek

2 weeks ago

$SKYT RUNNING HIGHER AGAIN! Glad I bought a TON more in the $9 range recently.

0 0 2 336 0

Brad Loncar @bradloncar

2 weeks ago

Roche to acquire 89bio for US$14.50 per share in cash, representing a total equity value of approximately US$2.4B. Stockholders would also receive a non-tradeable CVR for up to an aggregate of US$6.00 per share in cash.

9 12 123 25K 6

Paul Marganski @paulBIOgeek

3 weeks ago

Too f-ing bad for $BBIO 😂😂😂

Adam Feuerstein ✡️ @adamfeuerstein

3 weeks ago

Too f-ing bad for $BBIO 😂😂😂

16 9 45 22K 19

0 0 0 387 0

JD Vance @JDVance

3 weeks ago

Eternal rest grant unto him, O Lord.

13K 57K 512K 13.2M 8K

Download Image

Dirk Haussecker @RNAiAnalyst

4 weeks ago

$WVE if a year ago, u told me that clinical #RNAediting efficiencies can already be 60%+, monthly dosing, and no liver enzymes over half a year...that would have been considered dream scenario. #AATD great competition with CRISPR...which is really the only reason why stock could…

8 2 24 4K 8

Download Image

STAT @statnews

4 weeks ago

Biotech veterans John Maraganore and Clive Meanwell are launching Corsera, a new heart disease startup with lofty goals. trib.al/i15es2c

2 5 11 4K 0

Paul Marganski @paulBIOgeek

a month ago

Does Nancy Pelosi own $SKYT or something?? 😂😂🚀🚀

0 0 0 434 0

Adam Feuerstein ✡️ @adamfeuerstein

a month ago

$SRPT refinanced debt while abandoning patients with limb girdle muscular dystrophy and their families. CEO Doug Ingram talks about "tranforming the lives of patients with rare diseases," but that doesn't include kids like Jacob, 4, Sammy, 17 and others. My colleague…